Viva Biotech Holdings (VB0) — Cash Flow Reinvestment Rate
Viva Biotech Holdings (VB0) has a Cash Flow Reinvestment Rate of 0.37x as of June 2023, reinvesting €57.96 Million (capex €50.80 Million plus investments €7.15 Million) from operating cash flow of €158.72 Million. See VB0 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Viva Biotech Holdings Cash Flow Reinvestment Rate (2016–2024)
Historical reinvestment intensity for Viva Biotech Holdings across 9 annual periods. For the full cash flow conversion analysis, see VB0 cash flow metrics.
Annual Cash Flow Reinvestment Rate for Viva Biotech Holdings (2016–2024)
Year-by-year capital reinvestment analysis for Viva Biotech Holdings. See Viva Biotech Holdings leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.91x | €340.66 Million | €373.99 Million | €191.67 Million | ▲ +45.0% |
| 2023 | 0.63x | €240.78 Million | €383.40 Million | €187.84 Million | ▼ -18.5% |
| 2022 | 0.77x | €297.35 Million | €386.05 Million | €249.33 Million | ▼ -91.7% |
| 2021 | 9.31x | €724.23 Million | €77.83 Million | €565.18 Million | ▼ -44.0% |
| 2020 | 16.61x | €717.04 Million | €43.18 Million | €592.62 Million | ▲ +219.8% |
| 2019 | 5.19x | €238.95 Million | €46.01 Million | €56.19 Million | ▼ -14.4% |
| 2018 | 6.07x | €73.46 Million | €12.11 Million | €46.90 Million | ▲ +484.9% |
| 2017 | 1.04x | €28.92 Million | €27.89 Million | €18.92 Million | ▼ -18.7% |
| 2016 | 1.28x | €26.93 Million | €21.12 Million | €7.34 Million | — |